sftd

NeuRx DPS RA/4 Respiratory Stimulation System, FDA-Approved

Filed in archive FDA Approvals , Medical Devices , News on June 18, 2008

An implantable electronic device that stimulates the diaphragm and allows certain spinal cord injury patients to breathe for at least four hours a day without a mechanical ventilator - NeuRx DPS RA/4 Respiratory Stimulation System - has been approved by the US FDA.

The_NeuRx_DPS_System.gif



Patients with severe spinal cord injuries who cannot control their diaphragms often need mechanical ventilation to help them breathe. This usually requires a full-time connection to a ventilation machine.

The NeuRx DPS RA/4 uses four electrodes implanted in the muscle of the diaphragm to electronically stimulate contraction; this stimulation allows the patient to inhale.

The FDA approved the distribution of this device under a Humanitarian Device Exemption, an approval process for devices intended to treat or diagnose conditions that affect fewer than 4,000 people per year.


NeuRx DPS RA/4 Respiratory Stimulation System is manufactured by Synapse Biomedical.

Source: FDA News

Permalink: NeuRx DPS RA/4 Respiratory Stimulation System, FDA-Approved

Tags: NeuRx  DPS  RA/4  Respiratory  Stimulation  System  spinal  chord  injury  diaphragm  mechanical  ventilator  he 

Vote for NeuRx DPS RA/4 Respiratory Stimulation System, FDA-Approved:

  • Currently 6.40/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 6.40 out of 5 vote(s) cast.
 
Share It
RSSrss
Google google
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Most Popular   Allergies   Alzheimer's Disease   Arthritis   Bacteria and Bacterial Infections   Best of   Blog Carnivals   Bone Health   Cancer   Cardiovascular Health   Cases   CFS   Consumer Alert   Controversies   Dental Health   Diabetes   Diagnostics   Diarrhea   Did you know   Diet   Dietary Supplements and Vitamins